Trump Administration Cuts Medicare Drug Subsidy, Raising Costs for Seniors

Mehmet Oz, head of the Centers for Medicare and Medicaid Services (CMS), framed the decision as the elimination of a corporate "bailout." Oz asserted that most beneficiaries would see monthly premium increases of less than $10. However, internal projections reported by The Wall Street Journal suggest a steeper reality, with nearly half of enrollees likely facing monthly hikes between $11 and $20.

The policy reversal arrives during an ongoing affordability crisis, drawing sharp condemnation from healthcare advocates. Leslie Dach, chair of Protect Our Care, warned that for seniors on fixed incomes, even modest increases force impossible choices between medication, utilities, and groceries. Analysts at KFF note that the move may drive further migration toward privatized Medicare Advantage plans, a sector Oz championed extensively before his appointment. As the administration pivots away from the subsidy, Democratic critics argue the change represents a broader pattern of prioritizing tax relief for the wealthy while stripping away essential support for vulnerable retirees.